Slide 1: Teleflex Incorporated Acquisition of Vascular Solutions Conference Call
1 Teleflex Incorporated Acquisition of Vascular Solutions Conference Call December 2, 2016 Exhibit 99.2
Slide 2: Forward-looking statements and additional information
2 This presentation and our discussion contain forward-looking information and statements. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in the forward- looking statements, including, but not
Slide 3: Agenda
3 Agenda 1. Strategic Rationale 2. Transaction Overview 3. Vascular Solutions Overview 4. Financial Summary 5. Transaction Summary
Slide 4: Strategic Rationale
4 Strategic Rationale 1. Highly strategic and complementary acquisition − Significantly advances Teleflex’s offering of vascular and interventional solutions − Adds over 90 proprietary products and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologi
Slide 5: Vascular Solutions Transaction Overview
5 Vascular Solutions Transaction Overview Price • Purchasing VASC for $56.00 per share, or a transaction value of approximately $1.0 billion Valuation • ~ 5.4x 2017E revenue (midpoint of VASC management full-year revenue guidance) Integration • Proven track-record of successfully integrating acquisi
Slide 6: Vascular Solutions Overview
6 Vascular Solutions Overview • Innovative medical device company that focuses on bringing clinically advanced solutions to the market for treating coronary and peripheral diseases • Product line consists of over 90 devices and services that are sold to interventional cardiologists, interventional r
Slide 7: Financial Summary
7 Financial Summary 1. Similar to acquisition of Vidacare, the acquisition of Vascular Solutions accelerates Teleflex’s top-line growth profile with high-margin, differentiated product offerings 2. Prudent use of existing balance sheet capacity − Expect to fund at closing with $750 million senior se
Slide 8: Transaction Summary
8 Transaction Summary 1. Highly strategic and complementary acquisition 2. Accelerates Teleflex’s sales growth trajectory and provides significant sales channel opportunity 3. Improves R&D pipeline 4. Compelling financial profile that substantially improves Teleflex’s revenue growth, margins, earnin
Slide 9: Q&A
9 Q&A